MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Novel strategies based on sensory electrical stimulation to manage tremor in Parkinson’s disease. A pilot study.

    C. Montero Pardo, M. González Sánchez, A. Pascual Valdunciel, J. Sánchez Pérez, J. Camilo Moreno, F. Oliveira Barroso, F. Grandas, J. Luis Pons (Madrid, Spain)

    Objective: Tremor can be a disabling motor symptom in patients with Parkinson´s disease (PD) and in some patients is refractory to medication. Here we present…
  • 2022 International Congress

    What, when and how should the information on iRBD and risk of Parkinson’s disease and related conditions be communicated?

    H. Chohan, C. Simonet, A. Gill, A. Schrag, A. Noyce, L. Pérez-Carbonell (London, United Kingdom)

    Objective: To investigate what, when and how patients with iRBD would like to receive information regarding the potential future implications of having iRBD, once diagnosis…
  • 2022 International Congress

    Motor resonance flexibility to emotion-enriched context in Parkinson’s disease patients with and without freezing of gait.

    E. Pelosin, G. Lagravinese, A. Bisio, M. Bove, A. Botta, G. Bonassi, R. Marchese, S. Mezzarobba, P. Ruggeri, L. Avanzino (Genova, Italy)

    Objective: This study aims at exploring the response of the mirror neuron system, specifically motor resonance, to an emotion-enriched context in people with Parkinson disease…
  • 2022 International Congress

    Anti-α-synuclein antibody 5G4 differentiates idiopathic REM Sleep Behavior Disorder patients from healthy controls in skin biopsies

    S. Toth, K. Kulcsarova, E. Feketeova, J. Ventosa, M. Maretta, A. Kunova, M. Bekeova, P. Christova, J. Baloghova, E. Mechírová, Z. Gdovinova, M. Skorvanek (Kosice, Slovakia)

    Objective: The aim of our study was to assess α-synuclein (α-syn) staining using the 5G4 antibody in skin samples of patients with idiopathic REM Sleep…
  • 2022 International Congress

    Central olfactory structure atrophy is linked to synucleinopathy conversion in idiopathic REM sleep behavior disorder

    KA. Woo, JY. Lee, H. Kim, YK. Kim (Seoul, Republic of Korea)

    Objective: We hypothesized that early structural changes in the brain olfactory relevant structures may help early identification of those at risk of future disease conversion…
  • 2022 International Congress

    Patterns of early-phase 18F-FP-CIT PET images and the risk of dementia conversion in Parkinson’s disease

    S. Chung, P. Lee, Y. Kim, Y. Sohn (Yongin-si, Republic of Korea)

    Objective: This study aims to investigate the prognostic relevance of the patterns of early-phase 18F-fluorinated N-3-fluoropropyl-2-beta-carboxymethoxy-3-beta-(4-iodophenyl) nortropane (18F-FP-CIT) positron emission tomography (PET) images in patients…
  • 2022 International Congress

    Longitudinal predictors of quality of life in Parkinson’s disease: analysis of NILS cohort data at four years follow up

    C. Rodriguez-Blazquez, MJ. Forjaz, A. Rizos, P. Martinez-Martin, KR. Chaudhuri (Madrid, Spain)

    Objective: To analyze the change in quality of life (QoL) and its longitudinal predictors in a sample of Parkinson’s disease (PD) patients. Background: Natural progression…
  • 2022 International Congress

    Gait abnormalities relate to increased extracellular water in the substantia nigra in Parkinson’s disease patients

    M. Bange, G. Gonzalez-Escamilla, N. Lang, A. Radetz, H. Ding, D. Herz, W. Schöllhorn, M. Muthuraman, S. Groppa (Mainz, Germany)

    Objective: The aim of this study was to investigate the role of substantia nigra microstructural integrity in parkinsonian gait impairments. Background: Gait impairments are common…
  • 2022 International Congress

    Electrophysiological characteristics of tremor in patients with tick borne encephalitis

    M. Klarendic, N. Prezelj, K. Vogelnik, M. Kojovic (Ljubljana, Slovenia)

    Objective: To define electrophysiological characteristics of tremor in patients with tick borne encephalitis (TBE). Background: TBE is endemic in focal areas of Europe, including Slovenia. Besides typical…
  • 2022 International Congress

    The Vall d’Hebron Initiative for Parkinson (VHIP) cohort: a prospective, longitudinal and observational study enrolling de novo Parkinson’s disease (PD) patients and carriers of PD-linked mutations for biomarker and pathophysiology studies

    D. Samaniego-Toro, L. Domingo-Rodriguez, M. Camprodon-Gómez, M. Armengol-Bellapart, V. González, S. Lucas-Del-Pozo, E. Xicoy, J. Riera-Heredia, D. Montpeyó, M. Martinez-Vicente, A. Laguna, J. Hernandez-Vara (Barcelona, Spain)

    Objective: To describe the study protocol of the Vall d’Hebron Initiative for Parkinson (VHIP) cohort, a prospective, longitudinal and observational cohort study aimed at deeply…
  • « Previous Page
  • 1
  • …
  • 646
  • 647
  • 648
  • 649
  • 650
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley